Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Digitalis glycosides (digoxin and digitoxin) are the oldest drugs in cardiovascular (CV) medicine and have generally been used in patients with heart failure...

AbstractBackground and Aims. The aims of this study were to assess prescription patterns, dosages, discontinuation rates and association with prognosis of...

AbstractBackground and aims. STRONG-HF showed that rapid up-titration of guideline-recommended medical therapy (GRMT), in a high intensity care (HIC)...

Abstract. Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of major heart failure events, an action that is statistically linked to enhanced...

This editorial refers to ‘Outcomes of patients with atrial fibrillation and ischaemic stroke while on oral anticoagulation’, by A. P. Benz et al.,...

AbstractAims. Telemonitoring modalities in heart failure (HF) have been proposed as being essential for future organization and transition of HF care,...

Abstract. This 2023 statement updates clinical guidance for homozygous familial hypercholesterolaemia (HoFH), explains the genetic complexity, and provides...

Medical therapy for heart failure (HF) has made substantial progress during recent years, and the ‘fantastic four’ drugs angiotensin receptor–neprilysin...

AbstractAims. Oesophageal fistula represents a rare but dreadful complication of atrial fibrillation catheter ablation. Data on its incidence, management, and...

Abstract. Large-scale clinical trials are essential in cardiology and require rapid, accurate publication, and dissemination. Whereas conference...